000			03212nam a22004095c 4500
999			_c6525 _d6525
001			6525
003			ES-MaUEC
005			20200625155429.0
006			a||||fo|||| 00| 0
007			cr nn nnnanaaa
008			191114s2020 gw | s |||| 0|eng d
020			_a9783030311131
024	7		_a10.1007/978-3-030-31113-1 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM275 _b.A85 2020 EB
245	0	0	_aAtlas of Response to Immunotherapy _cedited by Egesta Lopci, Stefano Fanti.
250			_a1st ed. 2020.
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2020.
300			_a1 recurso en línea (VIII, 127 páginas) _b111 ilustraciones, 100 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aPART I BRIEF INTRODUCTION: Immunotherapy in oncology -- Evolution of response criteria -- Part II DIESEASE-ORIENTED APPLICATIONS: CNS -- Thorax -- Melanoma -- Gastrointestinal -- Genitourinary -- Hematologic -- Other tumor types -- PART III PITFALLS AND IMMUNE-RELATED ADVERSE EVENTS (IrAEs) PART IV IMMUNO-PET.
520	3		_aThis atlas is a concise but comprehensive guide to the diverse patterns of response to immunotherapy as observed on Positron Emission Tomography/Computed Tomography (PET/CT) and other conventional imaging modalities, including CT and Magnetic Resonance Imaging (MRI). The purpose for this publication is to fill the gap between the growing clinical relevance and utilization of immunotherapy in medical oncology, mainly based on checkpoint inhibitors, and the need for experienced imagers with reliable tools assessing response to treatment. A series of disease-oriented chapters will present the imaging findings during immunotherapy in the major oncological settings, with helpful comparison of functional (PET/CT) and morphological (CT/MRI) patterns of response in individual cases. To complete the atlas, a dedicated chapter will focus on major pitfalls and immune-related adverse events (irAEs) affecting image interpretation during the course of immunotherapy. The concluding chapter will lastly examine the available data and potential developments of immuno-PET, which is considered as the novel frontier of research in this oncological scenario. The atlas will be of high value for radiologists and nuclear medicine specialists at all levels of experience.
650		7	_2embne _9145440 _aInmunoterapia
700	1		_aLopci, Egesta. _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt _997182
700	1		_aFanti, Stefano. _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt _988787
710	2		_aSpringerLink (Online service) _9106937
776	0	8	_iPrinted edition: _z9783030311124
776	0	8	_iPrinted edition: _z9783030311148
776	0	8	_iPrinted edition: _z9783030311155
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-31113-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE _n0
998			_db _zSI